Deep Learning-Enabled Quantification of 99mTc-Pyrophosphate SPECT/CT for Cardiac Amyloidosis

被引:3
|
作者
Miller, Robert J. H. [1 ]
Shanbhag, Aakash [2 ,3 ]
Michalowska, Anna M. [2 ]
Kavanagh, Paul [2 ]
Liang, Joanna X. [2 ]
Builoff, Valerie [2 ]
Fine, Nowell M. [1 ]
Dey, Damini [2 ]
Berman, Daniel S. [2 ]
Slomka, Piotr J. [2 ]
机构
[1] Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada
[2] Cedars Sinai Med Ctr, Dept Med, Div Artificial Intelligence Med Imaging & Biomed S, Los Angeles, CA 90048 USA
[3] Univ Southern Calif, Signal & Image Proc Inst, Ming Hsieh Dept Elect & Comp Engn, Los Angeles, CA USA
关键词
cardiac amyloidosis; technetium pyrophosphate; quanti-; fication; diagnostic accuracy; biomarker; SCINTIGRAPHY; TOMOGRAPHY;
D O I
10.2967/jnumed.124.267542
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Transthyretin cardiac amyloidosis (ATTR CA) is increasingly recognized as a cause of heart failure in older patients, with 99mTc-pyrophosphate imaging frequently used to establish the diagnosis. Visual interpretation of SPECT images is the gold standard for interpretation but is inherently subjective. Manual quantitation of SPECT myocardial 99mTc-pyrophosphate activity is time-consuming and not performed clinically. We evaluated a deep learning approach for fully automated volumetric quantitation of 99mTc-pyrophosphate using segmentation of coregistered anatomic structures from CT attenuation maps. Methods: Patients who underwent SPECT/CT 99mTc-pyrophosphate imaging for suspected ATTR CA were included. Diagnosis of ATTR CA was determined using standard criteria. Cardiac chambers and myocardium were segmented from CT attenuation maps using a foundational deep learning model and then applied to attenuation-corrected SPECT images to quantify radiotracer activity. We evaluated the diagnostic accuracy of target-to-background ratio (TBR), cardiac pyrophosphate activity (CPA), and volume of involvement (VOI) using the area under the receiver operating characteristic curve (AUC). We then evaluated associations with the composite outcome of cardiovascular death or heart failure hospitalization. Results: In total, 299 patients were included (median age, 76 y), with ATTR CA diagnosed in 83 (27.8%) patients. CPA (AUC, 0.989; 95% CI, 0.974-1.00) and VOI (AUC, 0.988; 95% CI, 0.973-1.00) had the highest prediction performance for ATTR CA. The next highest AUC was for TBR (AUC, 0.979; 95% CI, 0.964-0.995). The AUC for CPA was significantly higher than that for heart-to-contralateral ratio (AUC, 0.975; 95% CI, 0.952-0.998; P 5 0.046). Twenty-three patients with ATTR CA experienced cardiovascular death or heart failure hospitalization. All methods for establishing TBR, CPA, and VOI were associated with an increased risk of events after adjustment for age, with hazard ratios ranging from 1.41 to 1.84 per SD increase. Conclusion: Deep learning segmentation of coregistered CT attenuation maps is not affected by the pattern of radiotracer uptake and allows for fully automatic quantification of hot-spot SPECT imaging such as 99mTcpyrophosphate. This approach can be used to accurately identify patients with ATTR CA and may play a role in risk prediction.
引用
收藏
页码:1144 / 1150
页数:7
相关论文
共 50 条
  • [1] Volumetric Evaluation of 99mTc-pyrophosphate SPECT/CT in the Diagnosis of Transthyretin Cardiac Amyloidosis
    Watanabe, S.
    Nakajima, K.
    Yoneyama, H.
    Wakabayashi, H.
    Inaki, A.
    Konishi, T.
    Komatsu, J.
    Yoshida, S.
    Kinuya, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S524 - S524
  • [2] 99mTc-Pyrophosphate Scintigraphy for Cardiac Amyloidosis: Concordance of Planar and SPECT/CT Imaging
    Coskun, N.
    Kartal, O.
    Erdogan, S.
    Ozdemir, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S539 - S539
  • [3] Absolute quantitative analysis of cardiac amyloidosis using SPECT/CT with 99mTc-pyrophosphate
    Yanagisawa, Shin
    Takahashi, Yusuke
    Sasaki, Jun
    Takasone, Ken
    Yoshie, Koji
    Koyama, Jun
    Katoh, Nagaaki
    Yazaki, Masahide
    Kuwahara, Koichiro
    Fujinaga, Yasunari
    Sekijima, Yoshiki
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2021, 28 (03): : 213 - 214
  • [4] Assessment of cardiac amyloidosis with 99mTc-pyrophosphate (PYP) quantitative SPECT
    Chao Ren
    Jingyun Ren
    Zhuang Tian
    Yanrong Du
    Zhixin Hao
    Zongyao Zhang
    Wei Fang
    Fang Li
    Shuyang Zhang
    Bailing Hsu
    Li Huo
    EJNMMI Physics, 8
  • [5] Assessment of cardiac amyloidosis with 99mTc-pyrophosphate (PYP) quantitative SPECT
    Ren, Chao
    Ren, Jingyun
    Tian, Zhuang
    Du, Yanrong
    Hao, Zhixin
    Zhang, Zongyao
    Fang, Wei
    Li, Fang
    Zhang, Shuyang
    Hsu, Bailing
    Huo, Li
    EJNMMI PHYSICS, 2021, 8 (01)
  • [6] Assessment of Cardiac Amyloidosis with 99mTc-Pyrophosphate (PYP) Quantitative SPECT
    Ren, Chao
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [7] Idiopathic inflammatory myopathy: Quantification of 99mTc-pyrophosphate uptake by SPECT/CT
    Thogersen, K. F.
    Hvidsten, S.
    Diederichsen, L. P.
    Jacobsen, S.
    Hoilund-Carlsen, P. F.
    Simonsen, J. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S171 - S172
  • [8] The importance of SPECT cardiac reconstruction for accurate 99mTc-pyrophosphate interpretation in TTR amyloidosis
    Poterucha, Timothy J.
    Elias, Pierre
    Ruberg, Frederick L.
    DeLuca, Albert
    Kinkhabwala, Mona
    Johnson, Lynne L.
    Maurer, Mathew S.
    Einstein, Andrew J.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2022, 29 (03) : 1478 - 1480
  • [9] Volumetric evaluation of 99mTc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters
    Watanabe, Satoru
    Nakajima, Kenichi
    Wakabayashi, Hiroshi
    Yoneyama, Hiroto
    Yoshida, Shohei
    Komatsu, Junji
    Konishi, Takahiro
    Inaki, Anri
    Kinuya, Seigo
    JOURNAL OF NUCLEAR CARDIOLOGY, 2022, 29 (06) : 3102 - 3110
  • [10] The importance of SPECT cardiac reconstruction for accurate 99mTc-pyrophosphate interpretation in TTR amyloidosis
    Timothy J. Poterucha
    Pierre Elias
    Frederick L. Ruberg
    Albert DeLuca
    Mona Kinkhabwala
    Lynne L. Johnson
    Mathew S. Maurer
    Andrew J. Einstein
    Journal of Nuclear Cardiology, 2022, 29 : 1478 - 1480